Continuous Glucose Monitoring (CGM) vs. BGM Strips

Continuous Glucose Monitoring (CGM) vs. BGM Strips

What's the Difference?

A blood glucose meter (BGM) and its test strips give you a snapshot: one reading, from one drop of blood, at one moment. A continuous glucose monitor (CGM) is a sensor worn under the skin that keeps measuring [2]. FDA's review of Abbott's FreeStyle Libre 3 Plus and 2 Plus sensors says the system "detects trends and tracks patterns," and the Dexcom G7 15 Day normally pairs each reading with a trend arrow [8] [7]. The two aren't really rivals. As of October 2026, the American Diabetes Association's Standards of Care say that people using CGM "must also have access to BGM at all times" [2].

How They Work

The two devices sample different fluids. A strip measures capillary blood from a fingerstick, while a CGM sensor sits in interstitial fluid (ISF), the fluid that surrounds cells just under the skin [2]. Glucose reaches ISF after it reaches the blood, and a review in the Journal of Diabetes Investigation put that delay at about 5 to 15 minutes [3]. When glucose is steady, the gap hardly shows. When it is rising or falling quickly, the sensor can trail the meter, and a modeling study found that this physiological lag alone was enough to explain why sensors looked less accurate during fast changes [4].

The Tech Behind It

Most test strips are tiny electrochemical cells. An enzyme on the strip, either glucose oxidase or glucose dehydrogenase, reacts with glucose in the blood drop, and the meter converts the resulting electrical signal into a number [2]. FDA's review of the Accu-Chek Guide system calls this a "quantitative amperometric assay," meaning the meter reads a current, and names the enzyme as an FAD-dependent glucose dehydrogenase [5]. Meters are judged against ISO 15197:2013, the international standard for self-testing blood glucose systems [1]. Its main accuracy criterion requires at least 95% of results to fall within ±15 mg/dL of a laboratory reference when glucose is below 100 mg/dL, and within ±15% at or above 100 mg/dL [6].

CGMs don't all share one chemistry. The Dexcom G7 15 Day sensor and Abbott's FreeStyle Libre 3 Plus and 2 Plus sensors are electrochemical, like strips: glucose oxidase on the sensor reacts with glucose in ISF and produces a current [7] [8]. Here's what surprised us: the Eversense 365 implant doesn't use that reaction at all. A fluorescent indicator on its surface glows more brightly as it binds glucose, and the system measures that change in light [9]. We cover each design in more depth in our guide to CGM sensor technology mechanisms.

CGM accuracy is usually reported as MARD, the mean absolute relative difference: the average gap between sensor readings and a laboratory reference, written as a percentage, where lower is better. In FDA's April 2025 review of the Dexcom G7 15 Day sensor, MARD against a YSI 2300 laboratory analyzer ran from 7.3% to 8.9% across the four stages of the 15-day wear period [7].

Which One Wins?

CGM is the better tool for trends, because a meter can't show direction or how long glucose stayed in a range. Time in Range, one of the core CGM metrics, comes from continuous sensor data, and the international consensus targets for it were written for CGM [12]. Sensors have their own failure modes, though. External pressure on a sensor can cause a compression artifact, a rapid drop in readings that doesn't reflect real glucose [10]. A sensor's sensitivity can also shift over its wear time, which shows up as drift away from blood glucose values [10]. Then there is bio-fouling: the sensor surface can be coated by the body's reaction to it, and a 2020 review still listed protective, biocompatible membrane coatings as an open challenge for electrochemical sensors [11]. That's where BGM strips earn their place, as a check on outliers.

The Verdict

For CGM users, the ADA's answer is both. Its 2026 Standards of Care list the moments a meter is still needed alongside a CGM: when a reading seems wrong, during sensor warm-up, when transmission drops, for calibration if the device requires it, when a warning message appears, when sensor supplies are delayed, and when glucose is changing fast [2]. Calibration is now the exception rather than the rule. The ADA notes that few real-time CGMs need user calibration [2], and the Dexcom G7 15 Day and FreeStyle Libre 3 Plus sensors are factory-calibrated [7] [8]. Eversense 365 is an exception, with four fingerstick calibrations at the start, one a day through day 13 and one a week after that [9]. The ADA also says every CGM system relies on a meter to confirm accuracy when a sensor reading doesn't match how a person feels, and Dexcom's G7 15 Day labeling likewise points users to a meter when sensor readings don't match low or high symptoms [2] [7]. That is why strips remain the tool for confirming hypoglycemia when the sensor and your symptoms disagree. What to do about any reading, from either device, is a decision for you and your care team.